Events

Innovative Health Initiative - Brokerage event for IHI's 2025 calls

When
NOV ’24
Tue
12
NOV ’24
Wed
13

This was 2 years ago

Location

Brussels

Programmes
  • Health

The Innovative Health Initiative will hold a brokerage event in Brussels on 12 & 13 November 2024.

The aim of the event is to provide people interested in IHI Call 9 for proposals with the opportunity to network face-to-face and start forming consortia. There will also be pitching sessions and poster sessions to give research organisations, patient groups and companies the chance to showcase their capabilities. Find the detailed agenda of the event here.

More information and registration for the brokerage event on the IHI website.

 

myOverview

Sign up for personalised information

Stay informed about Horizon Europe, Digital Europe & EDF, filtered on what matters to you.

  • News in your domains
  • Event announcements
  • A personal dashboard
Sign up now

Only for stakeholders located in Flanders

Event calendar

  • Health

Brain Innovation Days 2026

NOV
Wed
18
NOV
Thu
19

The Brain Innovation Days 2026 cover recent advances, challenges and opportunities in the field through talks, panel discussions, interactive sessions and networking.

Read more
  • Climate, Energy, Mobility

Horizon Europe Cluster 5 info day + GREENET Brokerage event

NOV
Thu
19

This hybrid information day is organised by the European Commission and looks at Horizon Europe Cluster 5 funding opportunities in climate, energy and mobility under the 2027 call topics. Onsite participants can ask questions directly or through Slido, and online participants can also use the Q&A tool. Questions are expected to be accepted...

Read more
  • EIC

EIC 2027 online information day

NOV
Thu
19

An overview of the upcoming EIC funding opportunities and new features introduced in 2027. Speakers from the European Innovation Council and SMEs Executive Agency (EISMEA) and the Directorate-General for Research and Innovation (DG RTD) of the European Commission will present an overview of the main EIC funding schemes:  EIC Pathfinder:...

Read more

Testimonial

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.